or Try an Advanced Search...

    Johnson & Johnson Stocks List

    Symbol Grade Name % Change
    KVUE A Kenvue Inc. -0.04
    JNJ D Johnson & Johnson -0.21
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Household & Personal Products
    Related Stock Lists: Pain S&P 500 Skin Care Allergy Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Care Products Contact Lens Contact Lenses Cough Diagnostic Products Dow Jones Component Energy Products Gastrointestinal General Surgery Glucose Hematology Immunology Infection

    Related ETFs - A few ETFs which own one or more of the above listed Johnson & Johnson stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 22.25
    IPO B Renaissance IPO ETF 9.85
    KNGS C Roundhill S&P Dividend Monarchs ETF 9.2
    FLV A American Century Focused Large Cap Value ETF 9.07
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 6.95
    View all Johnson & Johnson ETFs...
    Compare ETFs
    Compare IHE to FTXH Compare IHE to IPO Compare IPO to KNGS

        Johnson & Johnson Stocks Recent News

        Date Stock Title
        Nov 23 JNJ Hedge Funds Bet Big On Johnson & Johnson (JNJ): Top Healthcare Stock to Watch
        Nov 23 JNJ 3 Dividend Stocks That Are Screaming Buys in November
        Nov 23 JNJ 2 Unstoppable Dividend Stocks to Buy Now With $500
        Nov 23 JNJ 2 Dow Jones Dividend Stocks With Yields Above 3% You Can Buy Now and Hold at Least a Decade
        Nov 23 JNJ Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
        Nov 22 KVUE Layoffs in 2024: A List of Companies Cutting Jobs This Year
        Nov 22 JNJ Layoffs in 2024: A List of Companies Cutting Jobs This Year
        Nov 22 JNJ J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
        Nov 22 JNJ Medtronic acquires Fortimedix Surgical to boost surgical portfolio
        Nov 22 JNJ Sanofi Plans to Change Hospital Drug-Discount Program
        Nov 22 JNJ Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma
        Nov 22 JNJ Johnson & Johnson seeks FDA approval for its ulcerative colitis treatment
        Nov 22 JNJ Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others
        Nov 22 JNJ Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor
        Nov 22 JNJ Johnson & Johnson (NYSE:JNJ) Stock Goes Ex-Dividend In Just Three Days
        Nov 21 JNJ Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy
        Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
        Nov 19 JNJ Large caps in trouble? Key takeaways from Tommy Tuberville's latest trades
        Nov 19 JNJ Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive
        Nov 19 JNJ Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting
        Related Industries: Drug Manufacturers - Major Household & Personal Products
        Related Stock Lists: Pain S&P 500 Skin Care Allergy Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Care Products Contact Lens Contact Lenses Cough Diagnostic Products Dow Jones Component Energy Products Gastrointestinal General Surgery Glucose Hematology Immunology Infection
        Johnson & Johnson

        Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.
        Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $70.1 billion during calendar year 2015.
        Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses.

        More about Johnson & Johnson
        Browse All Tags